The city of Sarasota, Florida, currently has 1 active clinical trials seeking participants for COPD research studies.
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Recruiting
A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants with Chronic Obstructive Pulmonary Disease (COPD).
Gender:
ALL
Ages:
Between 40 years and 70 years
Trial Updated:
09/13/2024
Locations: Research Site 007, Sarasota, Florida
Conditions: COPD